India · Delayed Price · Currency is INR Indoco Remedies Statistics
Total Valuation
Indoco Remedies has a market cap or net worth of INR 21.01 billion. The enterprise value is 31.02 billion.
| Market Cap | 21.01B |
| Enterprise Value | 31.02B |
Important Dates
The last earnings date was Tuesday, October 27, 2026.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Sep 10, 2026 |
Share Statistics
Indoco Remedies has 92.30 million shares outstanding. The number of shares has decreased by -4.22% in one year.
| Current Share Class | 92.30M |
| Shares Outstanding | 92.30M |
| Shares Change (YoY) | -4.22% |
| Shares Change (QoQ) | -4.97% |
| Owned by Insiders (%) | 7.73% |
| Owned by Institutions (%) | 20.83% |
| Float | 49.57M |
Valuation Ratios
The trailing PE ratio is 66.48 and the forward PE ratio is 49.50.
| PE Ratio | 66.48 |
| Forward PE | 49.50 |
| PS Ratio | 1.10 |
| PB Ratio | 2.07 |
| P/TBV Ratio | 2.52 |
| P/FCF Ratio | 16.78 |
| P/OCF Ratio | 9.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.38, with an EV/FCF ratio of 24.77.
| EV / Earnings | 97.07 |
| EV / Sales | 1.63 |
| EV / EBITDA | 22.38 |
| EV / EBIT | 86.49 |
| EV / FCF | 24.77 |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 1.04.
| Current Ratio | 1.26 |
| Quick Ratio | 0.61 |
| Debt / Equity | 1.04 |
| Debt / EBITDA | 7.64 |
| Debt / FCF | 8.46 |
| Interest Coverage | 0.28 |
Financial Efficiency
Return on equity (ROE) is 3.19% and return on invested capital (ROIC) is 1.25%.
| Return on Equity (ROE) | 3.19% |
| Return on Assets (ROA) | 0.88% |
| Return on Invested Capital (ROIC) | 1.25% |
| Return on Capital Employed (ROCE) | 2.19% |
| Weighted Average Cost of Capital (WACC) | 8.02% |
| Revenue Per Employee | 3.18M |
| Profits Per Employee | 53,257 |
| Employee Count | 6,000 |
| Asset Turnover | 0.75 |
| Inventory Turnover | 1.63 |
Taxes
In the past 12 months, Indoco Remedies has paid 138.19 million in taxes.
| Income Tax | 138.19M |
| Effective Tax Rate | 30.30% |
Stock Price Statistics
The stock price has decreased by -15.47% in the last 52 weeks. The beta is 0.66, so Indoco Remedies's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -15.47% |
| 50-Day Moving Average | 238.60 |
| 200-Day Moving Average | 222.31 |
| Relative Strength Index (RSI) | 52.16 |
| Average Volume (20 Days) | 298,739 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Indoco Remedies had revenue of INR 19.09 billion and earned 319.54 million in profits. Earnings per share was 3.42.
| Revenue | 19.09B |
| Gross Profit | 12.39B |
| Operating Income | 358.65M |
| Pretax Income | 456.05M |
| Net Income | 319.54M |
| EBITDA | 1.30B |
| EBIT | 358.65M |
| Earnings Per Share (EPS) | 3.42 |
Balance Sheet
The company has 525.30 million in cash and 10.59 billion in debt, with a net cash position of -10.07 billion or -109.06 per share.
| Cash & Cash Equivalents | 525.30M |
| Total Debt | 10.59B |
| Net Cash | -10.07B |
| Net Cash Per Share | -109.06 |
| Equity (Book Value) | 10.16B |
| Book Value Per Share | 117.27 |
| Working Capital | 2.53B |
Cash Flow
In the last 12 months, operating cash flow was 2.29 billion and capital expenditures -1.04 billion, giving a free cash flow of 1.25 billion.
| Operating Cash Flow | 2.29B |
| Capital Expenditures | -1.04B |
| Depreciation & Amortization | 938.90M |
| Net Borrowing | 253.99M |
| Free Cash Flow | 1.25B |
| FCF Per Share | 13.57 |
Margins
Gross margin is 64.93%, with operating and profit margins of 1.88% and 1.67%.
| Gross Margin | 64.93% |
| Operating Margin | 1.88% |
| Pretax Margin | 2.39% |
| Profit Margin | 1.67% |
| EBITDA Margin | 6.80% |
| EBIT Margin | 1.88% |
| FCF Margin | 6.56% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 0.09%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 0.09% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 6.03% |
| FCF Payout Ratio | 1.47% |
| Buyback Yield | 4.22% |
| Shareholder Yield | 4.31% |
| Earnings Yield | 1.50% |
| FCF Yield | 5.96% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for Indoco Remedies is 256.00, which is 12.48% higher than the current price. The consensus rating is "Hold".
| Price Target | 256.00 |
| Price Target Difference | 12.48% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on May 17, 2012. It was a forward split with a ratio of 7.5.
| Last Split Date | May 17, 2012 |
| Split Type | Forward |
| Split Ratio | 7.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |